StockClub

TELO

TELOTelomir Pharmaceuticals, Inc. Common Stock$ --
Telomir Pharmaceuticals, Inc. Common Stock

Telomir Pharmaceuticals, Inc. Common Stock

TELO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -
Operating Income
-2M USD
YoY +26.5%
Net Income
-2M USD
YoY +28.9%
EPS
-0.06$
YoY +38.8%

Revenue

$0
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
Actual
$0 (-)

Net Income

$-10.4M
FY2024 Q1$-6.3M
$-6.3M
Q1
FY2024 Q2$-7.7M
$-7.7M
Q2
FY2024 Q3$-13.7M
$-13.7M
Q3
FY2024 Q4$-16.6M
$-16.6M
Q4
FY2025 Q1$-2.2M
$-2.2M
Q1
FY2025 Q2$-7.2M
$-7.2M
Q2
FY2025 Q3$-8.4M
$-8.4M
Q3
FY2025 Q4$-10.4M
$-10.4M
Q4
Actual
+$6.2M (+37.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025MISS
Actual:$0
Est:$1.5B
FY2025MISS
$0

Analyst Estimates